ENHNX
Price
$11.51
Change
+$0.03 (+0.26%)
Updated
Aug 21 closing price
Net Assets
155.11M
GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
Interact to see
Advertisement

ENHNX vs GSPQX

ENHNX vs GSPQX Comparison Chart in %
View a ticker or compare two or three
VS
ENHNX vs. GSPQX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENHNX is a Hold and GSPQX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. ENHNX (155M). ENHNX pays higher dividends than GSPQX: ENHNX (5.70) vs GSPQX (0.06). ENHNX was incepted earlier than GSPQX: ENHNX (11 years) vs GSPQX (21 years). GSPQX (1.86) is less costly to investors than ENHNX (1.27). ENHNX is a more actively managed with annual turnover of: 150.00 vs. GSPQX (29.00). GSPQX has a lower initial minimum investment than ENHNX: GSPQX (1000) vs ENHNX (1000000). ENHNX annual gain was more profitable for investors over the last year : 15.29 vs. GSPQX (13.89). ENHNX return over 5 years is better than : 32.79 vs. GSPQX (27.70).
ENHNXGSPQXENHNX / GSPQX
Total Expense Ratio0.751.7543%
Annual Report Gross Expense Ratio1.271.8668%
Fund Existence11 years21 years-
Gain YTD13.91812.651110%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets155M3.94B4%
Annual Yield % from dividends5.700.068,867%
Returns for 1 year15.2913.89110%
Returns for 3 years37.0539.7793%
Returns for 5 years32.7927.70118%
Returns for 10 years99.8975.02133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals